ASX News Health Care Noxopharm jumps as flagship lupus drug clears first-pass in vitro safety tests Noxopharm has reported its lupus medication in development, SOF-SKN, has passed first-stage in vitro safety tests… 2 mins04 February 2025 10:30 (AEDT)